go back

Nevada rates for HCPCS C9081

Idecabtagene vicleucel, up to 460 million autologous anti-BCMA CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Professionalmedian $501,187 · 10th–90th $501,187–$660,6930%50%90th$501,187

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample — interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$501,187.23 / $501,187.23 / $660,693.45